Abstract
AbstractRecently, there are several routes for COVID-19 vaccine research, yet their weaknesses lie in low efficiency, tolerability, immune adaptability and safety. We describe a new approach to COVID-19 based on engineered human mesenchymal stem cells(hu-MSC), which is like a small protein antigen response device, but will be gradually cleared and degraded by body’s immune system among recognization process. The antibody response results show that this is effective and fast. Furthermore, after several antibody response tests, we obtained an injection of a set of cocktail-like modified human mesenchymal stem cell line. This strategy opened a new avenue for vaccine design against COVID-19.
Publisher
Cold Spring Harbor Laboratory
Reference23 articles.
1. Mukherjee R. Global efforts on vaccines for COVID-19: Since, sooner or later, we all will catch the coronavirus. Journal of biosciences, 2020, 45(1):
2. Dhama K , Sharun K , Tiwari R , et al. COVID-19, an emerging coronavirus infection: advances and prospects in designing and developing vaccines, immunotherapeutics, and therapeutics. Hum Vaccin Immunother, 2020, 1-7.
3. Rational Vaccine Design in the Time of COVID-19
4. An Evidence Based Perspective on mRNA-SARS-CoV-2 Vaccine Development;Medical science monitor : international medical journal of experimental and clinical research,2020
5. The Challenges of Vaccine Development against a New Virus during a Pandemic;Cell Host Microbe,2020
Cited by
8 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献